Sunovion Applies for FDA Approval of SUN-101 and eFlow as Long-term COPD Treatment
COPD
Sunovion Pharmaceuticals has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA), seeking approval of its SUN-101/eFlow technology as a long-term maintenance treatment of airflow obstruction in adult ... Read more